Skip to main content
Clinical Trials/IRCT138705301059N1
IRCT138705301059N1
Completed
Phase 3

A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis

Pasteur Institute of Iran0 sites70 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
onychomycosis.
Sponsor
Pasteur Institute of Iran
Enrollment
70
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Presence of at least 25% involvement of the target nail, at least 2 mm of healthy nail from the nail fold to the proximal Dermatophyte onychomycosis border. Exclusion criteria: Non\-dermatophytic onychomycosis, hypersensitivity to Azole derivatives, unwilling to sign informed consent, receiving systemic anti\-fungal treatment or any investigational drug during three month prior to study

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials